These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21463253)

  • 1. Sex hormones, metabolic syndrome and kidney.
    Pérez-Torres I; Guarner V; El Hafidi M; Baños G
    Curr Top Med Chem; 2011; 11(13):1694-705. PubMed ID: 21463253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Gender and kidney diseases: the clinical importance and mechanisms of modifying effects].
    Grzegorczyk K; Krajewska M; Weyde W; Jakuszko K; Gniewek A; Klinger M
    Postepy Hig Med Dosw (Online); 2011 Dec; 65():849-57. PubMed ID: 22204762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadal steroids, salt-sensitivity and renal function.
    Pechere-Bertschi A; Burnier M
    Curr Opin Nephrol Hypertens; 2007 Jan; 16(1):16-21. PubMed ID: 17143066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the renin-angiotensin-aldosterone system in obesity-related renal diseases.
    Rüster C; Wolf G
    Semin Nephrol; 2013 Jan; 33(1):44-53. PubMed ID: 23374893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of sex steroid hormones and their signaling and metabolic pathways in the etiology of prostate cancer.
    Platz EA; Giovannucci E
    J Steroid Biochem Mol Biol; 2004 Nov; 92(4):237-53. PubMed ID: 15663987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex hormones and their influence on chronic kidney disease.
    Valdivielso JM; Jacobs-Cachá C; Soler MJ
    Curr Opin Nephrol Hypertens; 2019 Jan; 28(1):1-9. PubMed ID: 30320621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic syndrome, insulin resistance, and chronic allograft dysfunction.
    Porrini E; Delgado P; Torres A
    Kidney Int Suppl; 2010 Dec; (119):S42-6. PubMed ID: 21116317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches.
    Soltani Z; Washco V; Morse S; Reisin E
    Curr Hypertens Rep; 2015 Feb; 17(2):7. PubMed ID: 25620635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex steroid hormones, cardiovascular diseases and the metabolic syndrome.
    Baños G; Guarner V; Pérez-Torres I
    Cardiovasc Hematol Agents Med Chem; 2011 Jul; 9(3):137-46. PubMed ID: 21745183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender and the progression of chronic renal diseases: does apoptosis make the difference?
    Gandolfo MT; Verzola D; Salvatore F; Gianiorio G; Procopio V; Romagnoli A; Giannoni M; Garibotto G
    Minerva Urol Nefrol; 2004 Mar; 56(1):1-14. PubMed ID: 15195027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-reproductive effects of sex steroids: their immunoregulatory role.
    Arroyo IC; Montor JM
    Curr Top Med Chem; 2011; 11(13):1661-2. PubMed ID: 21463256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender and the renin-angiotensin-aldosterone system.
    Komukai K; Mochizuki S; Yoshimura M
    Fundam Clin Pharmacol; 2010 Dec; 24(6):687-98. PubMed ID: 20608988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of gender in the progression of renal disease.
    Silbiger SR; Neugarten J
    Adv Ren Replace Ther; 2003 Jan; 10(1):3-14. PubMed ID: 12616458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of renal damage and oxidative stress in a rat model of metabolic syndrome. Influence of gender.
    Pérez-Torres I; Roque P; El Hafidi M; Diaz-Diaz E; Baños G
    Free Radic Res; 2009 Aug; 43(8):761-71. PubMed ID: 19526391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity.
    Pasquali R; Vicennati V; Gambineri A; Pagotto U
    Int J Obes (Lond); 2008 Dec; 32(12):1764-79. PubMed ID: 18838976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty.
    Mauras N; Rogol AD; Haymond MW; Veldhuis JD
    Horm Res; 1996; 45(1-2):74-80. PubMed ID: 8742123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms involved in developmental programming of hypertension and renal diseases. Gender differences.
    Tomat AL; Salazar FJ
    Horm Mol Biol Clin Investig; 2014 May; 18(2):63-77. PubMed ID: 25390003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice.
    Hodgin JB; Knowles JW; Kim HS; Smithies O; Maeda N
    J Clin Invest; 2002 Feb; 109(4):541-8. PubMed ID: 11854327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension: renin-angiotensin-aldosterone system alterations.
    Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
    Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative pathways for angiotensin II production as an important determinant of kidney damage in endotoxemia.
    Rosa RM; Colucci JA; Yokota R; Moreira RP; Aragão DS; Ribeiro AA; Arita DY; Watanabe IK; Palomino Z; Cunha TS; Casarini DE
    Am J Physiol Renal Physiol; 2016 Sep; 311(3):F496-504. PubMed ID: 27252489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.